Taken together, changes in the gut microbiota-host interaction derived from the impairment in NLRP3 and NLRP6 inflammasome sensing, may govern the propensity for development of multiple metabolic syndrome-associated abnormalities such as NAFLD-NASH progression [168]. The gene discussed is NLRP6; the disease is metabolic dysfunction-associated steatotic liver disease.